Ignite Creation Date:
2024-05-06 @ 2:22 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04293562
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-22
First Post:
2020-02-18
Brief Title:
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 andor Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Organization Data
Organization:
Childrens Oncology Group
Class:
NETWORK
Study ID:
AAML1831
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |